|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/14 | (2006.01) |
| C07D 403/14 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Patento numeris | 3630751 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18734945.1 |
| Europos patento paraiškos padavimo data | 2018-05-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2018/053839 |
| Data | 2018-05-30 |
| (87) | Numeris | WO 2018/220546 |
| Data | 2018-12-06 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2017/086624 | 2017-05-31 | WO |
| (72) |
CUI, Kai , CN
KONG, Weiyong , CN
CASTRO-PALOMINO LARIA, Julio Cesar , ES
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
Palobiofarma, S.L. , Avenida Ernst Luch 32 TCM3-0401, 08302 Mataro (Barcelona), ES |
| (54) | CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1 H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS |
| CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1 H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS |